Vertex Announces Publication in The New England Journal of Medicine of Phase 3 Results for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in People With Cystic FibrosisBusiness Wire • 08/26/21
Buying Vertex Pharmaceuticals Stock Now Could Double Your Money Within 5 Years: Here's HowThe Motley Fool • 08/16/21